160 related articles for article (PubMed ID: 37391097)
1. Unraveling coagulation factor-mediated cellular signaling.
O'Donnell JS; Fleming H; Noone D; Preston RJS
J Thromb Haemost; 2023 Dec; 21(12):3342-3353. PubMed ID: 37391097
[TBL] [Abstract][Full Text] [Related]
2. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.
Diamond SL
Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416
[TBL] [Abstract][Full Text] [Related]
3. Homeostatic effects of coagulation protease-dependent signaling and protease activated receptors.
Isermann B
J Thromb Haemost; 2017 Jul; 15(7):1273-1284. PubMed ID: 28671351
[TBL] [Abstract][Full Text] [Related]
4. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
Hill-Eubanks DC; Parker CG; Lollar P
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
[TBL] [Abstract][Full Text] [Related]
5. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis.
Strukova S
Front Biosci; 2006 Jan; 11():59-80. PubMed ID: 16146714
[TBL] [Abstract][Full Text] [Related]
7. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor.
Béguin S; Kumar R; Keularts I; Seligsohn U; Coller BS; Hemker HC
Blood; 1999 Jan; 93(2):564-70. PubMed ID: 9885217
[TBL] [Abstract][Full Text] [Related]
8. Coagulation cascade proteinases in lung injury and fibrosis.
Chambers RC; Scotton CJ
Proc Am Thorac Soc; 2012 Jul; 9(3):96-101. PubMed ID: 22802281
[TBL] [Abstract][Full Text] [Related]
9. Polyphosphate binds to human von Willebrand factor in vivo and modulates its interaction with glycoprotein Ib.
Montilla M; Hernández-Ruiz L; García-Cozar FJ; Alvarez-Laderas I; Rodríguez-Martorell J; Ruiz FA
J Thromb Haemost; 2012 Nov; 10(11):2315-23. PubMed ID: 23006049
[TBL] [Abstract][Full Text] [Related]
10. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
Switzer ME; Gordon HJ; McKee PA
Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor signalling by coagulation proteases in endothelial cells.
Rezaie AR
Thromb Haemost; 2014 Nov; 112(5):876-82. PubMed ID: 24990498
[TBL] [Abstract][Full Text] [Related]
13. Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis.
Furlan M
Swiss Med Wkly; 2002 Apr; 132(15-16):181-9. PubMed ID: 12070783
[TBL] [Abstract][Full Text] [Related]
14. Factor VIIa/tissue factor-induced signaling: a link between clotting and disease.
Pendurthi UR; Rao LV
Vitam Horm; 2002; 64():323-55. PubMed ID: 11898395
[TBL] [Abstract][Full Text] [Related]
15. Coagulation and non-coagulation effects of thrombin.
Posma JJ; Posthuma JJ; Spronk HM
J Thromb Haemost; 2016 Oct; 14(10):1908-1916. PubMed ID: 27513692
[TBL] [Abstract][Full Text] [Related]
16. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
Chang P; Aronson DL; Borenstein DG; Kessler CM
Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004
[TBL] [Abstract][Full Text] [Related]
17. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
[TBL] [Abstract][Full Text] [Related]
18. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.
Terraube V; O'Donnell JS; Jenkins PV
Haemophilia; 2010 Jan; 16(1):3-13. PubMed ID: 19473409
[TBL] [Abstract][Full Text] [Related]
19. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
[TBL] [Abstract][Full Text] [Related]
20. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation.
Hess K; Ajjan R; Phoenix F; Dobó J; Gál P; Schroeder V
PLoS One; 2012; 7(4):e35690. PubMed ID: 22536427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
